SCHEMBL9739338

SCHEMBL9739338

CC(C)OC(OC(C)C)c1nc(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(C(C)C)n1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.33
AGTR2 P50052 1/20 0.33
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739129 0.90 AGTR1 (0.35) AGTR1AGTR2CNR2
SCHEMBL9738526 0.89 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9738817 0.89 CNR2 (0.34) AGTR1AGTR2CNR2
SCHEMBL9738101 0.86 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9740212 0.85 AGTR1 (0.35) AGTR1AGTR2CNR2
SCHEMBL9737759 0.85 TRPV1 (0.33) AGTR1AGTR2
SCHEMBL9739085 0.85 AGTR1 (0.36) AGTR1AGTR2CNR2
SCHEMBL9739175 0.85 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9738552 0.83 SLC33A1 (0.34) AGTR1
SCHEMBL9552979 0.81 AGTR1 (0.39) AGTR1AGTR2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed